Page last updated: 2024-08-25

bromopyruvate and Prostatic Neoplasms, Castration-Resistant

bromopyruvate has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bao, BY; Chen, YR; Cheng, WC; Chiu, CC; Chung, WJ; Chuu, CP; Huang, SP; Ke, CC; Lee, CH; Li, CY; Liu, PL; Su, CC; Wang, SC; Wu, HE; Wu, YH; Yeh, HC1

Other Studies

1 other study(ies) available for bromopyruvate and Prostatic Neoplasms, Castration-Resistant

ArticleYear
Novel insights into the anti-cancer effects of 3-bromopyruvic acid against castration-resistant prostate cancer.
    European journal of pharmacology, 2022, May-15, Volume: 923

    Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Humans; Male; Mice; Prostatic Neoplasms, Castration-Resistant; Pyruvates; Xenograft Model Antitumor Assays

2022